Chronic News and Research

RSS

Study reveals greater public support for reducing health care disparities among socio-economic groups

As Congress debates the public health care option, a recent study reveals greater public support for reducing health care disparities among socio-economic groups (i.e. by income or education) than among racial groups.

19 Oct 2009

New NIH grants to develop Patient-Reported Outcomes Measurement Information System

The National Institutes of Health announced today that it is awarding 15 new grants to further develop and test the Patient Reported Outcomes Measurement Information System (PROMIS).

19 Oct 2009

CONFIRMS trial demonstrates efficacy of ULORIC for treating hyperuricemia in patients with gout

Data presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology highlight effects of baseline characteristics on achievement of serum uric acid (sUA) levels to <6.0 mg/dL and the frequency of flares with ULORIC® (febuxostat) treatment.

19 Oct 2009

Cardium Therapeutics reports positive findings from Excellarate Phase 1/2 clinical study

Cardium Therapeutics today announced the publication of positive findings from the open label multi-center Phase 1/2 clinical study of Excellarate(TM) (GAM501, Ad5PDGF-B / 2.6% collagen), its product candidate for the potential treatment of non-healing diabetic foot ulcers.

19 Oct 2009

Mallinckrodt TaperGuard and TaperGuard Evac endotracheal tubes launched by Covidien

Covidien, a leading global healthcare products company and recognized innovator in mechanical ventilation and respiratory care devices, today announced the global launch of Mallinckrodt™ TaperGuard™ and TaperGuard™ Evac endotracheal tubes.

19 Oct 2009

Leahy's funds help physicians and independent pharmacies to adopt health information technology

More Vermont physicians will be using electronic prescribing and other health information technology to improve patient care, under a $1 million federal grant secured by U.S. Senator Patrick Leahy.

19 Oct 2009

Research programme to develop immunological biomarkers for chronic inflammatory diseases

Persistent inflammation and the activation of the immune system is the key pathological mechanism affecting many long-term conditions, such as rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn's disease and is the predominant mechanism underlying organ transplant rejection.

19 Oct 2009

Also in global health news: Street pharmacies; China health care; Hospital safety; African cardinals; Cells phones for health

Agence France-Presse examines Adjegounle, the "drugs" district in Benin. Although some are able to support their families by selling drugs at "street pharmacies," a minimum of "250 deaths and 340 cases of chronic illnesses linked to such drugs were recorded between April 2007 and June 2008," according to a medical thesis, the news service writes.

19 Oct 2009

Research study on epileptic seizures in individuals with alcohol withdrawal syndrome

Epileptic seizures are the most dramatic and prominent aspect of the "alcohol withdrawal syndrome" that occurs when a person abruptly stops a long-term or chronic drinking habit. Researchers have shown that the flow of calcium ions into brain cells via voltage-gated calcium channels plays an important role in the generation of alcohol withdrawal seizures, because blocking this flow suppresses these seizures.

19 Oct 2009

Coronary angiography does not affect kidney functioning in CKD patients, reveals study

A screening test that measures whether a patient's heart is healthy enough for a kidney transplant is not as dangerous as once thought, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

19 Oct 2009

Initiative calls for more research and improved treatment methods on musculoskeletal pain

The Global Year Against Musculoskeletal Pain launches today, focusing attention on one of the largest and most significant areas of pain.

19 Oct 2009

Recently approved Gleevec drug for cancer treatment

Investigators have identified a drug that is currently approved to treat certain types of cancer, Gleevec, that could provide the first treatment for scleroderma, a chronic connective tissue disease for which a treatment has remained elusive. The news will be presented at the annual meeting of the American College of Rheumatology on October 18 in Philadelphia.

19 Oct 2009

Findings may yield new treatments for COPD

A genetic mutation found in four children born with multiple abnormalities may provide insight into potential treatments for newborn lung distress and chronic obstructive pulmonary disease (COPD).

19 Oct 2009

Opinions: Fighting hunger; property ownership, trade key to Africa's development

"For one billion people around the world, the daily effort to grow, buy or sell food is the defining struggle of their lives. This matters to them, and to all of us," Secretary of State Hillary Rodham Clinton writes in a Times of India opinion piece.

19 Oct 2009

California study suggests more spending can save lives

An insurer in Utah is encouraging consumers to use less medical care, but a study of California hospitals suggests that sometimes spending more really does improve patient outcomes.

19 Oct 2009

Multi-million dollar cooperative agreement for SMA drug development program

Paratek Pharmaceuticals (Boston, MA) and Families of Spinal Muscular Atrophy (Elk Grove Village, IL) announced today that a jointly funded drug development program for Spinal Muscular Atrophy (SMA) has been awarded a multi-million dollar cooperative agreement from the National Institute of Neurological Disorders and Stroke (NINDS).

19 Oct 2009

BJUI: Testicular cancer survivors face an increased risk of long-term illness due to effective treatment

Testicular cancer survivors can face an increased risk of long-term illness, not because of the malignancy, but the highly effective treatment they receive, according to a study in the urology journal BJUI.

19 Oct 2009

AcelRx Pharmaceuticals’ programs to feature at upcoming annual meeting

AcelRx Pharmaceuticals, Inc. announced today that results of its Phase 1 studies evaluating the pharmacokinetics of its oral transmucosal NanoTab(TM) formulation of sufentanil will be featured in two oral presentations at the upcoming American Society of Anesthesiologists Annual Meeting in New Orleans.

15 Oct 2009

NFL, NDC launch 'Fuel Up to Play 60' to tackle childhood obesity

The NFL and National Dairy Council (NDC) today launch Fuel Up to Play 60, a new initiative aimed at tackling childhood obesity by giving youth a voice in changing the school nutrition and physical activity environment. The program will reach 36 million youth in 60,000 elementary, middle and high schools during the 2009/2010 school year.

15 Oct 2009

pSivida achieves milestone in Phase III Iluvien trial, last patient completes two-year follow up visit

pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that the last patient in the Phase III clinical trial being conducted by its collaborative partner, Alimera Sciences, for a new treatment for diabetic macular edema (DME) has completed the two-year follow up visit.

15 Oct 2009

Chronic News and Research

Study reveals greater public support for reducing health care disparities among socio-economic groups

New NIH grants to develop Patient-Reported Outcomes Measurement Information System

CONFIRMS trial demonstrates efficacy of ULORIC for treating hyperuricemia in patients with gout

Cardium Therapeutics reports positive findings from Excellarate Phase 1/2 clinical study

Mallinckrodt TaperGuard and TaperGuard Evac endotracheal tubes launched by Covidien

Leahy's funds help physicians and independent pharmacies to adopt health information technology

Research programme to develop immunological biomarkers for chronic inflammatory diseases

Also in global health news: Street pharmacies; China health care; Hospital safety; African cardinals; Cells phones for health

Research study on epileptic seizures in individuals with alcohol withdrawal syndrome

Coronary angiography does not affect kidney functioning in CKD patients, reveals study

Initiative calls for more research and improved treatment methods on musculoskeletal pain

Recently approved Gleevec drug for cancer treatment

Findings may yield new treatments for COPD

Opinions: Fighting hunger; property ownership, trade key to Africa's development

California study suggests more spending can save lives

Multi-million dollar cooperative agreement for SMA drug development program

BJUI: Testicular cancer survivors face an increased risk of long-term illness due to effective treatment

AcelRx Pharmaceuticals’ programs to feature at upcoming annual meeting

NFL, NDC launch 'Fuel Up to Play 60' to tackle childhood obesity

pSivida achieves milestone in Phase III Iluvien trial, last patient completes two-year follow up visit

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News